New treatments bring Kenya closer to goal of eradicating TB

Daniel Ng'etich joins other participants to march along Uhuru Highway at the launch of 'Mulika TB-Maliza TB' awareness campaign. [File]

Christine Mbali had high expectations when she started treatment for drug-resistant Tuberculosis in December 2017. For weeks before her diagnosis, a series of alarming symptoms had frightened her.

“A visit to the hospital led to my diagnosis with drug-resistant Tuberculosis.” But as she soon discovered, the Injectable Regimen [FM1], the TB treatment she was put on at the time, came with its fair share of challenges. She had to visit the clinic daily for some pills and an injection.